| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| HALBERT DAVID D | Founder, Chairman, and Chief Executive Officer. Exhibit 24 - Power of Attorney., Director, 10%+ Owner | C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING | David Halbert, /s/ J. Russel Denton, Attorney-in-Fact | 2025-06-17 | 0001034380 |
| Caris Halbert, L.P. | Director, 10%+ Owner | C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING | Caris Halbert, L.P., /s/ J. Russel Denton, Attorney-in-Fact | 2025-06-17 | 0002072109 |
| ADAPT I Ltd. | Director, 10%+ Owner | C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING | ADAPT I Ltd., /s/ J. Russel Denton, Attorney-in-Fact | 2025-06-17 | 0002072411 |
| Carisome I, L.P. | Director, 10%+ Owner | C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING | Carisome I, L.P., /s/ J. Russel Denton, Attorney-in-Fact | 2025-06-17 | 0002072412 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CAI | Common Stock | 2.02M | Jun 17, 2025 | Direct | F1 | |||||
| holding | CAI | Common Stock | 16.3M | Jun 17, 2025 | See Footnote | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CAI | Series A Preferred Stock | Jun 17, 2025 | Common Stock | 97.4M | $0.00 | See Footnote | F2, F3, F4 | ||||||
| holding | CAI | Series B Preferred Stock | Jun 17, 2025 | Common Stock | 7.41M | $0.00 | See Footnote | F2, F3, F4 | ||||||
| holding | CAI | Stock Option | Jun 17, 2025 | Common Stock | 2M | $2.44 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Includes 360,750 shares of Common Stock underlying restricted stock units which vest in accordance with the applicable grant agreement. |
| F2 | The Common Stock reported herein includes (i) 5,028,802 shares of Common Stock held of record by ADAPT I Ltd., (ii) 8,414,427 shares of Common Stock held of record by Carisome I, L.P., (iii) 645,149 shares of Common Stock held of record by Caris Investment II Ltd and (iv) 2,175,089 shares of Common Stock held of record by Caris Investment III Ltd. Caris Investment Management, LLC is the general partner of each of Caris Halbert, L.P., Caris Investment II Ltd., and Caris Investment III Ltd. Two family trusts are separately the general partner of ADAPT I Ltd. and the managing general partner of Carisome I, L.P., respectively. David D. Halbert is the managing member of Caris Investment Management, LLC and the trustee of each of the two family trusts, and in such capacities, has voting and investment power with respect to the shares held of record by each of the foregoing entities. Mr. Halbert disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
| F3 | Each share of preferred stock is convertible at the holder's option into 0.25 shares of Common Stock of the Issuer, subject to adjustment in accordance with the certificate of formation, and will automatically convert upon the closing of the initial public offering of the Issuer's Common Stock. |
| F4 | The preferred stock reported herein includes (i) 3,500,003 shares of Common Stock underlying Series A Preferred Stock held of record by ADAPT I Ltd., (ii) 93,854,124 shares of Common Stock underlying Series A Preferred Stock held of record by Caris Halbert, L.P. and (iii) 7,407,408 shares of Common Stock underlying Series B Preferred Stock held of record by Caris Halbert, L.P. Mr. Halbert disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
| F5 | The stock option is fully vested and exercisable. |
Founder, Chairman, and Chief Executive Officer. Exhibit 24 - Power of Attorney.